{{.infobox .infobox-gene}}
| Symbol | SPTBN4 |
| Full Name | Spectrin Beta Non-Erythrocytic 4 (βIV-Spectrin) |
| Chromosome | 19q13.13 |
| NCBI Gene ID | 10529 |
| OMIM | 607666 |
| Ensembl ID | ENSG00000197894 |
| UniProt ID | Q9H6G1 |
| Aliases | βIV-spectrin, KIAA1762 |
| Associated Diseases | ALS, CMT, neurodevelopmental disorders |
SPTBN4 encodes βIV-spectrin, a specialized spectrin isoform that localizes specifically to the axon initial segment (AIS) and nodes of Ranvier in neurons[@berg2019][@zuccotti2012]. The spectrin membrane skeleton provides structural support to the plasma membrane and organizes critical membrane microdomains. In neurons, βIV-spectrin partners with αIV-spectrin to form a specialized cytoskeletal scaffold that anchors voltage-gated sodium channels (Nav1.2, Nav1.6), voltage-gated potassium channels, and the critical scaffold protein AnkyrinG at the AIS[@komada2006][@wojtkowski2021].
The AIS is a specialized neuronal compartment located at the proximal axon that serves as the primary site of action potential initiation in most neurons. Proper organization of the AIS is essential for:
SPTBN4 is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
The SPTBN4 gene is located on chromosome 19q13.13 and encodes a 2,724-amino acid protein. βIV-spectrin is expressed primarily in the nervous system as multiple splice isoforms, with the longest isoform (βIV-spectrin) containing:
The protein forms heterodimers with αIV-spectrin, which further associate into tetramers to create the spectrin meshwork beneath the plasma membrane.
βIV-spectrin's primary function is organizing the axon initial segment[@berg2019][@leterrier2015]:
AnkyrinG recruitment: βIV-spectrin directly binds to AnkyrinG through a specialized binding motif. This interaction is essential for clustering AnkyrinG at the AIS, which in turn anchors the voltage-gated sodium channels.
Sodium channel anchoring: The βIV-spectrin/AnkyrinG complex provides the docking site for voltage-gated sodium channels (Nav1.2, Nav1.6). Mutations affecting this anchoring cause severe neuronal dysfunction.
Cytoskeletal scaffold: βIV-spectrin links the membrane proteins to the actin cytoskeleton, providing mechanical stability to the AIS membrane.
AtNodes of Ranvier, βIV-spectrin plays a similar organizational role:
paranodal junctions: βIV-spectrin helps organize the paranodal region where axons contact myelin-forming glial cells.
Sodium channel clustering: Nav1.6 channels are highly concentrated at the nodes, requiring βIV-spectrin for proper localization.
Saltatory conduction: The precise organization of ion channels at nodes is essential for the rapid, energy-efficient saltatory conduction of action potentials.
Beyond structural roles, the βIV-spectrin scaffold participates in signaling:
Second messenger signaling: The spectrin meshwork sequesters signaling molecules near the membrane.
Cytoskeletal regulation: βIV-spectrin interacts with Rho GTPases and other regulators of the actin cytoskeleton.
Protein quality control: The AIS contains specialized degradation machinery, and βIV-spectrin may participate in this process.
SPTBN4 is expressed exclusively in the nervous system:
| Cell Type | Expression | Location |
|---|---|---|
| CNS neurons | Very High | Axon initial segment |
| PNS neurons | Very High | Nodes of Ranvier |
| Oligodendrocytes | Low | Myelin sheaths |
| astrocytes | Not expressed | — |
Specific neuronal populations with high βIV-spectrin expression:
βIV-spectrin dysfunction may contribute to ALS pathogenesis[@galiano2012]:
AIS disruption: In ALS models, the AIS shows progressive disorganization before overt neurodegeneration. βIV-spectrin loss may compromise sodium channel clustering and neuronal excitability.
Axonal transport deficits: The spectrin cytoskeleton supports axonal transport. Disruption may impair delivery of essential cargoes to distal axons.
Motor neuron vulnerability: Motor neurons have extremely long axons requiring robust cytoskeletal infrastructure. βIV-spectrin mutations or dysfunction may render motor neurons particularly susceptible.
Dysregulated excitability: ALS neurons often show hyperexcitability, which may relate to AIS remodeling.
SPTBN4 variants cause a form of Charcot-Marie-Tooth disease (CMT):
Clinical features:
Pathogenesis: Impaired spectrin cytoskeleton in peripheral nerve axons disrupts internodal organization and axonal transport.
Dominant SPTBN4 mutations cause neurodevelopmental disorders[@hanlon2018]:
Clinical features:
Mechanism: Heterozygous mutations cause dominant-negative effects, disrupting AIS organization during development.
| Variant | Type | Phenotype |
|---|---|---|
| p.Arg501* | Nonsense | CMT, neurodevelopmental |
| p.Leu1612Pro | Missense | ALS risk |
| p.Arg2007Gln | Missense | Neuromyotonia |
| c.7508_7509del | Frameshift | Developmental delay |
βIV-spectrin dysfunction in ALS manifests in specific ways:
Limb-onset ALS: Most common form, starting in upper or lower limbs. Early AIS disruption may contribute to fasciculations and cramps.
Bulbar-onset ALS: Initial symptoms in facial muscles. AIS dysfunction may accelerate corticobulbar tract degeneration.
Respiratory onset: Rare presentation with early diaphragm weakness. Phrenic nerve motor neurons are particularly vulnerable.
SPTBN4-related CMT shows characteristic features:
Motor > sensory neuropathy: Motor symptoms predominate early.
Relatively slow progression: Unlike aggressive ALS, CMT progresses over decades.
Foot deformities: Develop over time due to muscle imbalance.
Neuromyotonia: Continuous muscle fiber activity causing stiffness, myotonia, and muscle rippling.
Developmental trajectory: Delays noted in infancy; intellectual disability varies.
Key diagnostic findings:
Nerve conduction studies (NCS):
Electromyography (EMG):
Single-fiber EMG:
MRI:
Sequencing approaches:
ALS standard of care:
CMT management:
AIS stabilization:
Gene therapy approaches:
βIV-spectrin is highly conserved:
| Species | Ortholog | Identity |
|---|---|---|
| Human | SPTBN4 | 100% |
| Mouse | Sptbn4 | 96% |
| Zebrafish | sptbn4 | 78% |
| Drosophila | β-Spec | 65% |
Mouse models: Knockout and transgenic mice available.
Zebrafish: Transparent embryos allow AIS visualization.
In vitro systems: Cultured neurons from patient iPSCs.
Potential biomarkers for βIV-spectrin disorders:
Outcome measures:
[@berg2019]: Berg et al. The axon initial segment as a membrane domain. Nat Rev Neurosci. 2019;20(2):81-96.
[@komada2006]: Komada et al. Neuronal spectrin membrane skeleton. J Neurosci. 2006;26(32):8319-8329.
[@stankewicz2020]: Stankewicz et al. βIV-spectrin mutations causing neurodegenerative disease. J Neurosci. 2020;40(15):2991-3003.
[@galiano2012]: Galiano et al. A distal axon injury signature predicts ALS progression. Exp Neurol. 2012;237(2):282-294.
[@zuccotti2012]: Zuccotti et al. Spectrin functions in neuronal development. Dev Neurobiol. 2012;72(11):1532-1546.
[@wojtkowski2021]: Wojtkowski et al. Ankyrin-G and spectrin at the axon initial segment. J Cell Biol. 2021;220(4):e202009154.
[@komura2015]: Komura et al. βIV-spectrin and ankyrin-G cooperate to stabilize the AIS. Cell Rep. 2015;12(10):1609-1620.
[@hanlon2018]: Hanlon et al. SPTBN4 mutations cause neurodevelopmental disorder. Am J Hum Genet. 2018;103(5):826-834.
[@leterrier2015]: Leterrier et al. The axon initial segment: the nexus of neuronal polarity. Neuron. 2015;88(5):892-901.
[@ogawa2019]: Ogawa et al. Spectrin cytoskeleton and AIS plasticity in disease. Neuroscience. 2019;408:277-294.
[@yamagata2022]: Yamagata et al. Axon initial segment dysfunction in ALS. Acta Neuropathol. 2022;144(3):395-411.
[@jang2017]: Jang et al. βIV-spectrin and AnkyrinG in neuronal disease. J Neurosci. 2017;37(14):3613-3624.
[@lefranc2018]: Lefranc et al. Spectrin mutations in Charcot-Marie-Tooth disease. Brain. 2018;141(5):1415-1428.
[@devaux2019]: Devaux et al. SPTBN4 and neuronal excitability. Front Cell Neurosci. 2019;13:263.
[@benhaddou2020]: Benhaddou et al. AIS plasticity in health and disease. Neuroscience. 2020;451:287-301.